Novel Research Model Offers Hope to ALS and MS Patients

Scientists at the Karolinska Institute in Sweden say they have developed a new disease model for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS’ that can be used to develop new immunotherapies. The model is described in a paper (“ Fatal demyelinating disease is induced by monocyte-derived macrophages in the absence of TGF-β signaling ”) in Nature Immunology . “The cytokine transforming growt